The differential effects of thiazolidindiones on atherogenic dyslipidemia in type 2 diabetes: what is the clinical significance?

Giovam Battista Rini, Manfredi Rizzo, Kaspar Berneis, Emanuel R. Christ, Giatgen A. Spinas

Risultato della ricerca: Article

17 Citazioni (Scopus)

Lingua originale	English
pagine (da-a)	2295-2303
Numero di pagine	9
Rivista	Expert Opinion on Pharmacotherapy
Volume	9
Stato di pubblicazione	Published - 2008

All Science Journal Classification (ASJC) codes

Pharmacology
Pharmacology (medical)

Accesso al documento

OA Link

Cita questo

Rini, G. B., Rizzo, M., Berneis, K., Christ, E. R., & Spinas, G. A. (2008). The differential effects of thiazolidindiones on atherogenic dyslipidemia in type 2 diabetes: what is the clinical significance? Expert Opinion on Pharmacotherapy, 9, 2295-2303.

@article{bd91b9e1cd664be8a8da31cc6eb69c97,

title = "The differential effects of thiazolidindiones on atherogenic dyslipidemia in type 2 diabetes: what is the clinical significance?",

keywords = "Thiazolidindiones,Atherogenic dyslipidemia",

author = "Rini, {Giovam Battista} and Manfredi Rizzo and Kaspar Berneis and Christ, {Emanuel R.} and Spinas, {Giatgen A.}",

year = "2008",

language = "English",

volume = "9",

pages = "2295--2303",

journal = "Expert Opinion on Pharmacotherapy",

issn = "1465-6566",

publisher = "Informa Healthcare",

}

TY - JOUR

T1 - The differential effects of thiazolidindiones on atherogenic dyslipidemia in type 2 diabetes: what is the clinical significance?

AU - Rini, Giovam Battista

AU - Rizzo, Manfredi

AU - Berneis, Kaspar

AU - Christ, Emanuel R.

AU - Spinas, Giatgen A.

PY - 2008

Y1 - 2008

KW - Thiazolidindiones,Atherogenic dyslipidemia

UR - http://hdl.handle.net/10447/36379

M3 - Article

VL - 9

SP - 2295

EP - 2303

JO - Expert Opinion on Pharmacotherapy

JF - Expert Opinion on Pharmacotherapy

SN - 1465-6566

ER -